Women's Dermatologic Society

  Advances in Dermatology: 2024 in Review  By Cather McKay, MD The past year has been another exciting one in the field of dermatology! New medications and expanded indications give us more options than ever to care for our patients.   Atopic dermatitis and prurigo nodularis More topical options for atopic dermatitis (AD) became available this year with the approval of roflumilast 0.15% cream (Zoryve) in patients aged 6 years and up and tapinarof 1% cream (Vtama) in patients aged 2 years and up. 1,2 Approval of the pan-JAK inhibitor delgocitinib cream for adults with chronic hand eczema is expected based on phase 3 trials. 3 Ruxolitinib cream (Opzelura) is currently approved for ages 12 and up, but has shown safety and efficacy in patients as young as 2 years. 4 IL-13 inhibitor lebrikizumab (Ebglyss) was approved in September for moderate to severe AD in patients 12 years and up who weigh at least 40 kg. 5 Another IL-13 inhibitor, cendakimab, is in develo...

Tips for Applying to the Pediatric Dermatology Fellowship Special thanks to Drs. Marcia Hogeling and Jennifer Huang for providing tips on how to best prepare and apply for a pediatric dermatology fellowship! Dr. Hogeling serves as the Director of Pediatric Dermatology at UCLA. Dr. Huang serves as the Director of Pediatric Oncodermatology and Program Director of the Harvard Combined Dermatology Residency Program.    1. What steps should applicants take if they are interested in a pediatric dermatology fellowship? Hogeling – Join Pediatric Dermatology organizations like the Society for Pediatric Dermatology and PeDRA. This is a great way to meet other Pediatric Dermatologists and they both have mentorship programs. Meet with a Pediatric Dermatologist in your residency program or affiliated with your residency program as a mentor to discuss your career goals. Consider having your resident continuity clinic in Pediatric Dermatology. Huang - There are currently 40 AC...